Voriconazole Associated Adverse Drug Events and Drug Monitoring in Lung Transplant (LTx) Recipients

Voriconazole is the drug of choice for prophylaxis and treatment of Aspergillus infection in LTx recipients. Voriconazole has a narrow therapeutic index; thus, therapeutic drug monitoring (TDM) is required to prevent treatment failure and reduce the risk of adverse drug events (ADE). We aim to determine the frequency and type of ADE associated with voriconazole and describe voriconazole dosing and TDM in LTx recipients.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: C.Y. Luo, R.G. Nador, R.D. Levy, J. Yee, L. Wei, N. Partovi Tags: (1297) Source Type: research